Fri, January 26, 2018
Thu, January 25, 2018
Wed, January 24, 2018

Matthew Taylor Maintained (ABT) at Buy with Increased Target to $70 on, Jan 25th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-70-on-jan-25th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Matthew Taylor of Barclays, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $66 to $70 on, Jan 25th, 2018.

Matthew has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Sean Lavin of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 22nd, 2018
  • Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017


This is the rating of the analyst that currently disagrees with Matthew


  • Vijay Kumar of "Evercore ISI Group" Initiated at Buy and Held Target at $64 on, Wednesday, January 3rd, 2018